Nuggehally Srinivas

Computer Sciences Corp. provided information technology solutions. It operated through the global business services, global infrastructure services segments. The company was founded by Roy Nutt and Fletcher Roseberry Jones on April 16, 1959 and was headquartered in Tysons, VA.

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA.

HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

Part of Nanomune Technologies, Inc., Aspira Biosystems, Inc. develops technology that enables the capture of targeted proteins. The private company is based in San Francisco, CA. The company was founded by Casey Crawford Lynch. Aspira Biosystems was acquired by Nanomune Technologies, Inc. on July 20, 2004.

Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

YMCA of San Diego County operates as a non-profit organization that offers enrichment programs. It focuses in the areas of youth development, healthy living, and social responsibility. The company was founded by George Marston in 1882 and is headquartered in San Diego, CA.

Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA.

The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr.

Neuroinsights LLC provides consultation and advice on investing in the neurotech industry. The company was founded by Casey and Zach Lynch and is headquartered in San Francisco, CA.

Pharmaco LSR, Inc. provides clinical research services.

IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden.

Tarrant Capital IP LLC operates as a venture capital firm. It serves the consumer, retail, technology, internet, healthcare, energy, cleantech, digital media, real estate, renewables and transportation industries. The company was founded by David Bonderman and Jim Coulter in 1992 and is headquartered in San Francisco, CA.

DoveTail Integrated Systems, Inc. develops platform solutions to deliver pre-engineered, pre-fabricated, pre-qualified manufacturing facilities suitable for a bio-pharmaceutical production processes including therapeutic proteins, vaccine, and fill finish configurations. The firm’s products include PlantConnex System and BioTypeKit. The company was founded by Bart van Praag and Gregg J. Pacchiana in 2010 and is headquartered in Hillsborough, NC.

Greenwich Biosciences, Inc. develops and markets cannabinoid prescription medicines through online. The company is headquartered in Carlsbad, CA.

California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019.

ARS Pharmaceuticals, Inc. develops epinephrine nasal sprays for treatment of severe allergic reactions to food, medication, and insect bites. The company was founded by Richard E. Lowenthal, Sarina Tanimoto and Robert Bell and is headquartered in San Diego, CA.

Lighthouse Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that specializes in precision medicine approaches to address major unmet medical needs. The private company is based in San Francisco, CA. The company's expertise lies in small molecule protease inhibition. Lighthouse's lead program, LHP588, is a phase 2b ready orally bioavailable small molecule that targets a specific infectious pathogen, Porphyromonas gingivalis. This pathogen is associated with chronic degenerative and inflammatory disorders such as dementia, periodontal disease, atherosclerosis, and orodigestive cancers. Lighthouse Pharmaceuticals was founded in 2022 by Casey Crawford Lynch, who has been the CEO since 2022.